Related Experiment Video
Updated: Jun 21, 2026
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Improved survival after rectal cancer in Denmark
S Bülow1, H Harling, L H Iversen
1Department of Surgery, Hvidovre University Hospital, Hvidovre, Denmark. sbulow@dadlnet.dk
Summary
Survival rates for rectal cancer in Denmark have significantly improved since 1994, likely due to Danish Colorectal Cancer Group (DCCG) initiatives. This includes advancements in surgical techniques and treatment centralization.
Area of Science:
- Oncology
- Public Health
- Surgical Outcomes
Background:
- Previous analysis in 1995 indicated a poorer rectal cancer prognosis in Denmark compared to Scandinavian neighbors.
- The Danish Colorectal Cancer Group (DCCG) was formed to address this disparity and enhance patient outcomes.
Purpose of the Study:
- To conduct a survival analysis of rectal cancer patients treated between 1994 and 2006.
- To evaluate the impact of DCCG initiatives on rectal cancer survival rates in Denmark.
Main Methods:
- Utilized data from the National Rectal Cancer Registry, National Colorectal Cancer Database, and Central Population Registry.
- Performed actuarial analysis of overall and relative survival for 10,632 surgically treated patients.
Main Results:
- Overall 5-year survival increased from 37% in 1994 to 51% in 2006.
- Relative 5-year survival improved from 46% to 62% during the study period.
- Significant survival gains were observed in men, women, and particularly in stage III rectal cancer patients.
Conclusions:
- Rectal cancer prognosis in Denmark has substantially improved.
- Key contributing factors likely include DCCG's implementation of total mesorectal excision, enhanced staging accuracy, and centralized treatment strategies.
